Exploring Pfizer Stock (NYSE:PFE) and its Potential Weight Loss Catalyst
Monday, 15 July 2024, 19:10
Pfizer Stock (NYSE:PFE): Super Cheap, 5.7% Yield, Potential Weight Loss Catalyst
Overview:
Pfizer (PFE) stock has been struggling, but stands out with a super cheap valuation, strong 5.7% dividend yield, and a weight loss drug candidate in development.
Analysis:
- Potential Catalyst: A new weight loss drug candidate holds promise.
- Analysts' Forecast: Projected 17.1% upside potential in the stock.
Delve into why Pfizer may offer substantial gains for investors in the near future.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.